divislab glp-1 novo nordisk A $60 billion industry just found its next growth lever. π With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight-loss and diabetes drugs Novo Nordisk: Intense Competition Within
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 29 - Sep 3
























